Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
Journal
Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
pubmed:
9
9
2022
medline:
10
2
2023
entrez:
8
9
2022
Statut:
ppublish
Résumé
Oral inhibitors of the platelet P2Y
Identifiants
pubmed: 36075236
doi: 10.1055/s-0042-1753479
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Pharmaceutical Preparations
0
Purinergic P2Y Receptor Antagonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
150-158Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
S.A.O.F.R. has nothing to declare. R.F.S. reports research grants and personal fees from AstraZeneca, Cytosorbents, GlyCardial Diagnostics and Thromboserin, and personal fees from Alnylam, Bayer, Bristol Myers Squibb/Pfizer, Chiesi, CSL Behring, HengRui, Idorsia, Intas Pharmaceuticals, Medscape, Novartis, PhaseBio, Portola, and Sanofi Aventis. F.A. reports lecture or consultancy fees from Amgen, AstraZeneca, Bayer, BMS/Pfizer, and Daiichi Sankyo. P.C. has previously or currently been involved in research contracts, consulting, and speaker bureau or received research and educational grants from: Abbott, AstraZeneca, Aventis, Abiomed, Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Eli-Lilly, Evolva, Fiberx, Idorsia, Janssen, Merck, Myogen, Medtronic, Mitsubishi Pharma, The Medicines Company, Nycomed, Organon, Pfizer, Pharmacia, Regado, Sanofi, Searle, Servier. J.M.T.B. reports grants from the Netherlands Organization for Health Research and Development, a Dutch government institution called ZonMw. J. M. ten Berg reports speaker fees from AstraZeneca, Daiichi Sankyo, Eli Lilly, the Medicines Company, Accumetrics, Boehringer-Ingelheim, Bayer, BMS, Pfizer, and Ferrer.